MYC and neoplasm: Among the immunoprecipitate identified by MS, the focus of attention was MYC proto-oncogene, bHLH transcription factor (c-Myc) (Fig. 4A, B), which can regulate the transcriptional expression of PDL1 by binding to the PDL1 promoter and act as an essential motor of tumor growth and immune evasion [36].